1651-2227/asset/olbannercenter.gif?v=1&s=aed7f4736e780f26e96740fe0c8faf09ec8d2946)
Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome
Article first published online: 22 MAR 2007
DOI: 10.1111/j.1651-2227.2007.00263.x
©2007 The Author/Journal Compilation © 2007 Foundation Acta Pædiatrica/Acta Pædiatrica
Additional Information
How to Cite
Verder, H. (2007), Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatrica, 96: 482–484. doi: 10.1111/j.1651-2227.2007.00263.x
Publication History
- Issue published online: 22 MAR 2007
- Article first published online: 22 MAR 2007
- Received 24 January 2007; revised 4 February 2007; accepted 6 February 2007.
- Abstract
- Article
- References
- Cited By
Keywords:
- Bronchopulmonary dysplasia;
- Nasal continuous positive airway pressure;
- Respiratory distress syndrome;
- Surfactant;
- Very-low-birthweight infants
Abstract
Prenatal steroids, early nasal CPAP combined with early surfactant treatment followed by extubation to nasal CPAP, and if necessary mechanical ventilation is a very effective treatment of respiratory distress syndrome. This treatment package is part of the ‘Scandinavian model’ for treatment of very-low-birthweight infants which also comprises gentle ventilation at birth; minimal handling; ‘neonatal individualized development care and assessment program’; high priority of breast feeding; and use of kangaroo method and which facilitates observation and nursing of sick premature infants and optimizes the possibility for early mother–child contact.
The incidence of bronchopulmonary dysplasia seems to be less of a problem in centres preferring nasal CPAP as the primary treatment for respiratory distress syndrome.